A new system for advanced drug screening using microimaging technology
Official title: Four-dimensional multi-modality microimaging-microdevice system for high throughput drug screening in vivo
Funded at Brigham and Women's Hospital · NIH-10915495 · Data updated 2026-11-12
This study is working on a new technology that helps test how well different drugs work in living organisms, which could lead to more personalized and effective treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 30, 2022 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $174,263 |
| NIH project number | 5K25EB032900-03 |
| Project ID | NIH-10915495 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who are undergoing treatment for conditions that require new drug therapies or personalized medicine approaches.
✕Less likely to help
Patients who are not seeking new treatment options or those with conditions that are not addressed by the drugs being screened may not benefit from this research.
What this research studies
This research focuses on developing a cutting-edge microimaging and microdevice system that allows for high-throughput drug screening in living organisms. By combining advanced optical imaging techniques with innovative microdevices, the project aims to enhance the drug development process and improve personalized healthcare. Patients may benefit from this technology as it could lead to more effective and tailored treatments based on individual responses to drugs. The research involves in vivo testing, which means it will be conducted in living subjects to assess how drugs interact with tissues.
Why it matters
Potential benefit: If successful, this research could significantly improve the efficiency and effectiveness of drug development, leading to better treatment options for patients.
How similar studies have gone: Other research has shown promise with similar microimaging techniques, indicating that this approach could lead to significant advancements in drug screening.
Where this research is happening
-
Brigham and Women's Hospital
Boston, United States Active
Researchers
- Principal investigator: Liu, Guigen — Brigham and Women's Hospital
- Study coordinator: Liu, Guigen
Related research
Other NIH-funded projects on the same topics.
-
Targeted therapies for glioblastoma in adults and kids
A large NIH program is exploring new brain cancer therapies, including drugs that reach the brain and work against glioblastoma in both children and adults.
-
Statins to Prevent Cancer-Associated Blood Clots in Cancer Patients
A large study will test whether taking rosuvastatin every day for a year can lower the chance of dangerous blood clots in people with cancer, without raising the risk of bleeding.
-
Preterm infant body composition and early-life health after NICU stay
This grant studies how body composition in very preterm babies relates to later brain development and risk of obesity or diabetes, with findings meant to improve care from NICU through early childhood.
-
Rapid Emergency Skills for Prehospital Optimization and Delivery (RESPOND) for Guatemala
A lightweight, AI-enabled prehospital training and triage program helps volunteer firefighters in Guatemala deliver faster, better care to trauma patients.
-
Rapid Emergency Skills for Prehospital Optimization and Notification in Guatemala
A mobile, AI-powered training and triage program helps volunteer emergency responders in Guatemala provide faster, safer trauma care and notify hospitals more quickly.
-
Understanding antibiotic allergy to improve care for patients
Scientists are testing new ideas to understand why some people develop severe allergic reactions to antibiotics and how to prevent or treat them.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.